Cargando…

Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective

AIMS: This study aims to establish the feasibility, safety, and efficacy of outpatient intravenous (IV) diuretic treatment for the management of decompensated heart failure (HF) for patients enrolled in the HeartFailure@Home service. METHODS AND RESULTS: We retrospectively analysed the clinical epis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Fozia Z., Taylor, Joanne K., John, Anju V., Khan, Muhammad A., Zaidi, Amir M., Mamas, Mamas A., Motwani, Manish, Cunnington, Colin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497198/ https://www.ncbi.nlm.nih.gov/pubmed/34382749 http://dx.doi.org/10.1002/ehf2.13368

Ejemplares similares

Correction: Cardiac implantable electronic device (CIED) infections are expensive and associated with prolonged hospitalisation: UK Retrospective Observational Study
por: Ahmed, Fozia Zahir, et al.
Publicado: (2019)

Cardiac implantable electronic device (CIED) infections are expensive and associated with prolonged hospitalisation: UK Retrospective Observational Study
por: Ahmed, Fozia Zahir, et al.
Publicado: (2019)

The added value of hypertonic saline solution to furosemide monotherapy in patients with acute decompensated heart failure: A meta‐analysis and trial sequential analysis
por: Diaz‐Arocutipa, Carlos, et al.
Publicado: (2023)

One-Month Global Longitudinal Strain Identifies Patients Who Will Develop Pacing-Induced Left Ventricular Dysfunction over Time: The Pacing and Ventricular Dysfunction (PAVD) Study
por: Ahmed, Fozia Zahir, et al.
Publicado: (2017)

Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
por: de Grooth, Harm-Jan S, et al.
Publicado: (2014)

Early diagnosis of cardiac implantable electronic device generator pocket infection using (18)F-FDG-PET/CT
por: Ahmed, Fozia Zahir, et al.
Publicado: (2015)

Triage‐HF Plus: a novel device‐based remote monitoring pathway to identify worsening heart failure
por: Ahmed, Fozia Zahir, et al.
Publicado: (2019)

A Pharmacogenetic Investigation of Intravenous Furosemide in Decompensated Heart Failure: A Meta-Analysis of 3 Clinical Trials
por: de Denus, Simon, et al.
Publicado: (2016)

Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study
por: Rahhal, Alaa, et al.
Publicado: (2019)

Women Hospitalized for Acute on Chronic Decompensated Systolic Heart Failure Receive Less Furosemide Compared to Men
por: Rasmussen, Tyler P., et al.
Publicado: (2019)

Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: Effect on thoracic fluid content
por: Ragab, Dalia, et al.
Publicado: (2018)

Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome
por: Frățilă, Georgiana, et al.
Publicado: (2023)

Intravenous furosemide vs nebulized furosemide in patients with pulmonary edema: A randomized controlled trial
por: Barzegari, Hasan, et al.
Publicado: (2021)

Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
por: Ibrahim, Ayman, et al.
Publicado: (2020)

Evaluation of diuretic efficiency of intravenous furosemide in patients with advanced heart failure in a heart failure clinic
por: Herrera-Leaño, Nancy, et al.
Publicado: (2023)

Novel atrioventricular sequential pacing approach using a transvenous atrial pacemaker and a leadless pacemaker: a case report
por: Guella, Elhosseyn, et al.
Publicado: (2021)

Effects of intravenous furosemide plus small‐volume hypertonic saline solutions on markers of heart failure
por: Tuttolomondo, Antonino, et al.
Publicado: (2021)

Association of time‐to‐intravenous furosemide with mortality in acute heart failure: data from REPORT‐HF
por: Ouwerkerk, Wouter, et al.
Publicado: (2022)

Intravenous iron therapy among patients with heart failure and iron deficiency: An updated meta-analysis of randomized controlled trials
por: Hamed, Mohamed, et al.
Publicado: (2023)

Protecting the most vulnerable during COVID-19 and beyond: a case report on the remote management of heart failure patients with cardiac implantable electronic devices
por: Ahmed, Fozia Zahir, et al.
Publicado: (2020)

A retrospective evaluation of the efficacy of intravenous bumetanide and comparison of potency with furosemide
por: Nappi, Jean M.
Publicado: (2013)

Early ambulatory discharge is safe and feasible after transradial coronary interventions
por: Aydin, Alper, et al.
Publicado: (2014)

Echocardiographic predictors of change in renal function with intravenous diuresis for decompensated heart failure
por: Gannon, Stephen A., et al.
Publicado: (2018)

Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure
por: Yoshioka, Kenji, et al.
Publicado: (2022)

Atrial Fibrillation in Heart Failure: An Innocent Bystander?
por: Khan, MA, et al.
Publicado: (2012)

The Application of Dopamine Combined with Intravenous Furosemide Infusion Therapy Has an Apparent Clinical Effect in Treating Patients with Heart Failure
por: Shi, Jinzheng, et al.
Publicado: (2022)

Effects of two‐dose intravenous administration of furosemide on clinical variables, electrocardiographic indices and serum electrolytes in dromedary calves
por: Samimi, Amir Saeed, et al.
Publicado: (2020)

Comorbidity health pathways in heart failure patients: A sequences-of-regressions analysis using cross-sectional data from 10,575 patients in the Swedish Heart Failure Registry
por: Lawson, Claire A., et al.
Publicado: (2018)

Second Decline in Admissions With Heart Failure and Myocardial Infarction During the COVID-19 Pandemic
por: Wu, Jianhua, et al.
Publicado: (2021)

‘Door-to-furosemide’ timing: early treatment of heart failure
por: Piazza, Vito
Publicado: (2019)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020)

Effects of acute systemic dehydration promoted by intravenous furosemide on respiratory mucus in dogs
por: Nakagawa, NK, et al.
Publicado: (2001)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

Ultra‐high dose intravenous nitroglycerin in an ESRD patient with acutely decompensated heart failure
por: Gyory, Michael, et al.
Publicado: (2021)

OUTpatient intravenous LASix Trial in reducing hospitalization for acute decompensated heart failure (OUTLAST)
por: Hamo, Carine E., et al.
Publicado: (2021)

Addition of Tolvaptan Compared With Increased Dose of Furosemide in Heart Failure Patients With Chronic Kidney Disease Under Furosemide Treatment
por: Tanaka, Toshiki, et al.
Publicado: (2018)

Retracted: The Application of Dopamine Combined with Intravenous Furosemide Infusion Therapy Has an Apparent Clinical Effect in Treating Patients with Heart Failure
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic
por: Shoaib, Ahmad, et al.
Publicado: (2021)

Nurse‐led ambulatory care supported by non‐invasive haemodynamic assessment after acute heart failure decompensation
por: Krzesiński, Paweł, et al.
Publicado: (2021)

Decompensated heart failure
por: Mangini, Sandrigo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9qrtfhq5ap29nkkmiel2guohq9